{"id":"W6958715052","doi":"10.6084/m9.figshare.c.6815738","title":"Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2− advanced breast cancer receiving first-line ribociclib plus fulvestrant","year":2023,"lang":"en","type":"other","venue":"Figshare","topic":"Legal and Regulatory Analysis","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Fulvestrant; Placebo; Hazard ratio; Cancer; Letrozole; Proportional hazards model; Breast cancer; Overall survival; Discontinuation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002538525,0.0005683185,0.001218426,0.0003622998,0.0002425457,0.0009202549,0.0005267133,0.0005337908,0.002624733],"category_scores_gemma":[0.001354229,0.0001538191,0.00144092,0.0004274635,0.0002437892,0.0004828559,0.0005774419,0.001173762,0.0003141386],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006170795,"about_ca_system_score_gemma":0.0006311252,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001184257,"about_ca_topic_score_gemma":0.004830577,"domain_scores_codex":[0.9994304,0.0002939338,0.00003553858,0.00009601861,0.00007669345,0.00006741066],"domain_scores_gemma":[0.9993563,0.0001385784,0.0001974107,0.00007111789,0.00005055611,0.0001861141],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.7847285,0.002108045,0.07030156,0.002527104,0.009701851,0.0002657085,0.0002267467,0.006619218,0.00825563,0.0006089332,0.01379042,0.1008663],"study_design_scores_gemma":[0.278317,0.1155477,0.5339638,0.0006605269,0.0202332,0.0009175248,0.000294805,0.006452298,0.003846983,0.001966804,0.03762041,0.0001789524],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"other","genre_scores_codex":[0.9734582,0.011277,0.0003810584,0.0006251307,0.0001503818,0.0003637563,0.009562986,0.00004811527,0.004133251],"genre_scores_gemma":[0.9784389,0.002052292,0.0003439279,0.000641935,0.0001956095,0.0007251545,0.01557803,0.00001701222,0.00200708],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.002624733,"threshold_uncertainty_score":0.01342517,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02568492124329212,"score_gpt":0.2820047223580319,"score_spread":0.2563198011147398,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}